BackLAW
NADA crackdown on doping supply chain in Najafgarh
A joint task force raided Gaurav Vats Nutrition in Najafgarh, Delhi, as part of a crackdown on a supply chain distributing WADA-prohibited substances. Investigations linked the shop to illegal performance-enhancing drug distribution, with lab tests confirming prohibited and contaminated substances. Authorities noted licensing violations under the Drugs and Cosmetics Act and FSS Act and signaled further raids.
Why It Matters
This event signals India’s intensified efforts to curb illegal PED trade and protect athlete health through inter-agency collaboration and enforcement.
Timeline
5 Events
Premises of Gaurav Vats Nutrition raided; licensing violations found
April 24, 2026
The premises of Gaurav Vats Nutrition were raided. The shop was found to be operating without mandatory licenses required under the Drugs and Cosmetics Act, 1940 and FSS Act.
Formal communication issued to regulatory bodies for intervention
April 24, 2026
In light of the findings, formal communication was issued to regulatory bodies for necessary intervention and further action under applicable laws.
NADA sends substances to NFSU for analysis; findings confirm prohibition and contamination
April 24, 2026
NADA procured substances and sent them to the National Forensic Sciences University (NFSU) for analysis. Laboratory findings confirmed that the substances were WADA-prohibited, and additionally found them to be contaminated with other prohibited substances, indicating quality and safety concerns.
NADA identifies Gaurav Vats in connection with anti-doping violations
April 24, 2026
NADA's Intelligence & Investigations (I&I) unit identified an individual, Mr. Gaurav Vats, in connection with alleged violations of the anti-doping rules for selling of prohibited substances in sports.
WADA President Witold Banka visits India and holds high-level meetings
April 2026
During the visit, WADA President Witold Banka held high-level meetings with Sports Minister Mansukh Mandaviya, NADA DG Anant Kumar, CBI Special Director Manoj Sashidhar, and other stakeholders, emphasizing the need to curb illegal trade of performance-enhancing drugs in India.